As BRAF mutation was more frequent in mucinous groups than non-mucinous carcinoma, as demonstrated by the present study and others (Ogino et al, 2006), the poor prognosis associated with mucinous histology may be at least partially explained by BRAF gene mutation. The gene discussed is BRAF; the disease is mucinous adenocarcinoma.